Royalty Pharma plc - Class A Ordinary Shares, par value $0.0001 per share (RPRX)

CUSIP: G7709Q104

Q4 2023 13F Holders as of 31 Dec 2023

Holder snapshot 7 signals
Share change
+3,084,147
Put/Call ratio
70%
SEC-reported price per share
$28.09
Number of holders
359
Value change
+$90,598,401
Number of buys
205
Open additional details 1 more signal available
Number of sells
139
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
445,144,313

Security key

G7709Q104

Report period

Q4 2023

Institutions

359

Top holders

10

Ownership snapshot

Top reported holders of RPRX - Royalty Pharma plc - Class A Ordinary Shares, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
MORGAN STANLEY
Disclosed value leader
MORGAN STANLEY
Comparable rows
15/15
Latest evidence
30 Sep 2023
13F Lead comparable stake: 11% Showing 1-6 of 15 holder rows.

Quick read

MORGAN STANLEY leads the comparable SEC ownership view at 11%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens MORGAN STANLEY's linked filing trail.
Comparable ownership Top 5
MORGAN STANLEY 11%
VANGUARD GROUP INC 8.9%
FMR LLC 6.8%
BlackRock Finance, Inc. 4.6%
BAILLIE GIFFORD & CO 4.1%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
MORGAN STANLEY
13F
Company
13F
11%
$1,306,319,218
48,132,615 shares
30 Sep 2023
VANGUARD GROUP INC
13F
Company
13F
8.9%
$1,070,329,787
39,437,354 shares
30 Sep 2023
FMR LLC
13F
Company
13F
6.8%
$825,793,457
30,427,172 shares
30 Sep 2023
BlackRock Finance, Inc.
13F
Company
13F
4.6%
$558,103,004
20,563,854 shares
30 Sep 2023
BAILLIE GIFFORD & CO
13F
Company
13F
4.1%
$495,068,448
18,241,284 shares
30 Sep 2023
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
13F
2.2%
$267,057,600
9,840,000 shares
30 Sep 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
359
Shares
310,848,061
Rows available
359
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2023 vs Q3 2023 Across Filers

Q3 2023 holders
312
Q4 2023 holders
359
Holder diff
47
Investor Q3 2023 Shares Q4 2023 Shares Share Diff Share Chg % Q3 2023 value Q4 2023 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .